Keytruda Market – Immunotherapy's Role in Modern Cancer Treatment
The Keytruda Market centers on pembrolizumab, an immunotherapy medicine that targets the PD-1 pathway. By blocking this immune checkpoint, the medicine can help the immune system recognize and attack certain cancer cells. Its use depends on the cancer type, disease stage, treatment setting, biomarker results where applicable, and current regulatory approvals. Current Market Landscape Keytruda...
0 Commentaires 0 Parts 4 Vue 0 Aperçu
Moundo https://moundo.social